Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 14, 2011Journal of Clinical Oncology

Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial

View Full Paper
Ask AI
Bookmark
Share

Authors

FMFrédéric MillotCentre Hospitalier Universitaire de PoitiersABAndré BaruchelUniversité Paris CitéJGJoëlle GuilhotInstitut Bergonié

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Millot et al. (2011) studied this question.

synapsesocial.com/papers/6aaa078c71e43eb1ac558632https://doi.org/10.1200/jco.2010.32.7114
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Detection of BCR-ABL Mutations and Resistance to Imatinib Mesylate2006 · 68 citations
  2. 2Prolonged Survival in Chronic Myelogenous Leukemia after Cytogenetic Response to Interferon-α Therapy1995 · 432 citations
  3. 3European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor2008 · 329 citations
  4. 4Imatinib for Newly Diagnosed Patients With Chronic Myeloid Leukemia: Incidence of Sustained Responses in an Intention-to-Treat Analysis2008 · 555 citations